"lexaria bioscience"

4Front Ventures Corp. Debuts Terp Stix, an Award-Winning, Distillate-Infused Pre-Roll Brand to Illinois Cannabis Consumers

Company's Proprietary Infusion Process Evenly Distributes High-quality Distillate with Indoor-grown Flower to Deliver a Sleek, Flavorful and Canoe-Free Consumption Experience

Launch Leverages 4front's In-depth Knowledge of Consumer Preferences and Low-cost Cultivation and Production Methodologies, Delivering Infused Pre-roll Singles at an Affordable Price Point to Illinois Customers

4Front Ventures Corp . ( CSE: FFNT ) ( OTCQX: FFNTF ) ( "4Front" or the "Company" ), a vertically integrated, multi-state cannabis operator and retailer, announced the launch of Terp Stixâ„¢ in Illinois . The Company's award-winning, distillate-infused pre-rolls are now available in one gram singles at 4Front's Mission Dispensaries in South Chicago and Calumet City Illinois for $25.00 . 4Front will continue to roll out its Terp Stixâ„¢ singles to partner dispensaries across the state in the coming weeks and months.

"The award-winning infused pre-rolls have been a huge hit among both lifestyle and medicinal consumers in markets like Washington and Massachusetts , and we're confident our customers in Illinois are going to fall in love with our Terp Stixâ„¢ singles," said 4Front EVP of Retail Operations, Gabe Mendoza . "With more than 20 recreational cannabis brands and 2,000 products, we believe our future success lies in our ability to bring first-rate, reasonably priced finished goods to market in a timely manner. As we look to add additional value to both our customers and shareholders, we remain focused on improving our operational efficiencies, streamlining our cultivation and production methodologies and capitalizing on our speed and agility in bringing products to market to gain a competitive marketplace advantage."

According to the cannabis analytics firm Headset , in 2020, sales of cannabis pre-rolls surged nearly 50% in key adult-use markets, surpassing expectations during the global pandemic. Today, pre-rolls are the second-fastest-growing product category among cannabis consumers who shop for value products and enjoy the convenience of prepackaged consumer packaged goods.

Responding to growing consumer demand for high-quality products at affordable price points, 4Front designed its Terp Stixâ„¢ singles specifically for cannabis consumers who have a high tolerance using the Company's proprietary infusion process to homogenize its high-quality distillate and indoor-grown flower. Terp Stixâ„¢ pre-rolls deliver a smooth, controlled and canoe-free consumption experience, and are available to Illinois consumers in the following varieties: High Times Cannabis Cup winner Tiger's Blood; Blueberry; Green Apple; Pineapple; Strawberry; and Tangerine.

For more information, visit https://4frontventures.com/ and https://missiondispensaries.com/ .

About 4Front Ventures Corp.
4Front Ventures Corp . ( "4Front" of the "Company") ( CSE: FFNT ) ( OTCQX: FFNTF ) is a national, vertically integrated multi-state cannabis operator with operations in strategic medical and adult-use cannabis markets, including California , Illinois , Massachusetts , Michigan and Washington . Since its founding in 2011, 4Front has built a strong reputation for its high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. To date, 4Front has successfully brought to market more than 20 different cannabis brands and nearly 2,000 unique product lines, which are strategically distributed through its fully owned and operated Mission dispensaries and retail outlets in its core markets. As the Company continues to drive value for its shareholders, its team is applying its decade of expertise in the sector across the cannabis industry value chain and ecosystem. For more information, visit https://4frontventures.com/ .

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/4front-ventures-corp-debuts-terp-stix-an-award-winning-distillate-infused-pre-roll-brand-to-illinois-cannabis-consumers-301335970.html

SOURCE 4Front

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/July2021/19/c8355.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)
4Front Ventures

4Front Ventures

Designed for longterm success across the United States.

Designed for longterm success across the United States. Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest Press Releases

Related News